Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Kewaunee Scientific Corp Market Cap
Based on ratings from 1 stock analysts, the Kewaunee Scientific Corp stock price is expected to decrease by 100% in 12 months. This is calculated by using the average 12-month stock price forecast for Kewaunee Scientific Corp. The lowest target is $ and the highest is $. Please note analyst price targets are not guaranteed and could be missed completely.
About 1 Wall Street analysts have assignedKEQU 1 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Kewaunee Scientific Corp to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on KEQU. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of KEQU.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
Data Not Found! | ||||
When did it IPO
1992
Staff Count
1,006
Country
United States
Sector/Industry
Consumer Cyclical/Furnishings, Fixtures & Appliances
CEO
Mr. Thomas D. Hull III
Market Cap
$119.8M
In 2023, KEQU generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that KEQU's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Wed, 27 Nov 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Kewaunee Scientific Corporation (NASDAQ: KEQU) will release its Q2 fiscal 2025 financial results on December 11, 2024, after market close.
Why It Matters - Kewaunee Scientific's upcoming financial results release could impact stock performance, providing insights into the company's fiscal health and growth prospects.
Fri, 01 Nov 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Kewaunee Scientific Corporation announced the acquisition of Nu Aire for $55 million, subject to adjustments for debt and other expenses.
Why It Matters - Kewaunee's acquisition of Nu Aire for $55 million could enhance its market position and growth potential, impacting future revenue and profitability, crucial for stock performance.
Mon, 23 Sep 2024
Sentiment - NEGATIVE
Source - Zacks Investment Research
Summary - Zacks initiates coverage of KEQU with a "Neutral" rating, citing a strong order backlog and stable domestic growth, despite international challenges and competitive pressures in the lab furniture market.
Why It Matters - Zacks' "Neutral" rating on KEQU signals cautious optimism, highlighting strong order backlog and domestic growth, which could influence investor sentiment amid market competition.
Thu, 19 Sep 2024
Sentiment - NEUTRAL
Source - Zacks Investment Research
Summary - The Analyst Blog features The Home Depot, The Southern Company, Infosys, Kewaunee Scientific, and Friedman Industries.
Why It Matters - The inclusion of these companies in the analyst blog may indicate potential investment opportunities or insights, influencing market perceptions and stock performance.
Tue, 17 Sep 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - Kaskela Law LLC is investigating Kewaunee Scientific Corporation (NASDAQ: KEQU) for potential violations of securities laws and fiduciary duties to shareholders.
Why It Matters - The investigation into Kewaunee Scientific may signal potential legal issues or governance failures, which could affect stock performance and shareholder value.
Thu, 12 Sep 2024
Sentiment - NEGATIVE
Source - Zacks Investment Research
Summary - KEQU's Q1 earnings are affected by delays in international shipments, particularly in India, due to customer construction site issues.
Why It Matters - Delays in shipments can lead to lower revenue and earnings for KEQU, potentially affecting stock performance and investor confidence.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
